Your browser doesn't support javascript.
loading
Post-Exposure Protection in Mice against Sudan Virus by a Two Antibody Cocktail.
Froude, Jeffrey W; Herbert, Andrew S; Pelat, Thibaut; Miethe, Sebastian; Zak, Samantha E; Brannan, Jennifer M; Bakken, Russell R; Steiner, Alexander R; Yin, Gang; Hallam, Trevor J; Sato, Aaron K; Hust, Michael; Thullier, Philippe; Dye, John M.
Afiliação
  • Froude JW; US Army Medical Research Institute for Infectious Disease (USAMRIID), Fort Detrick, MD 21702, USA. Jeffrey.w.froude2.mil@mail.mil.
  • Herbert AS; US Army Medical Research Institute for Infectious Disease (USAMRIID), Fort Detrick, MD 21702, USA. andrew.s.herbert4.ctr@mail.mil.
  • Pelat T; Unite de Biotechnologie des Anticorps, Institut de Recherche Biomedicale des Armees (IRBA-CRSSA), La Tronche 38516, France. t.pelat@orange.fr.
  • Miethe S; Institut für Biochemie, Biotechnologie und Bioinformatik, Technische Universität Braunschweig, Braunschweig 38106, Germany. miethe.sem@icloud.com.
  • Zak SE; US Army Medical Research Institute for Infectious Disease (USAMRIID), Fort Detrick, MD 21702, USA. samantha.e.zak.ctr@mail.mil.
  • Brannan JM; US Army Medical Research Institute for Infectious Disease (USAMRIID), Fort Detrick, MD 21702, USA. jennifer.m.brannan.ctr@mail.mil.
  • Bakken RR; US Army Medical Research Institute for Infectious Disease (USAMRIID), Fort Detrick, MD 21702, USA. russell.r.bakken.civ@mail.mil.
  • Steiner AR; Sutro Biopharma Inc., South San Francisco, CA 94080, USA. asteiner@sutrobio.com.
  • Yin G; Sutro Biopharma Inc., South San Francisco, CA 94080, USA. gyin@sutrobio.com.
  • Hallam TJ; Sutro Biopharma Inc., South San Francisco, CA 94080, USA. thallam@sutrobio.com.
  • Sato AK; Sutro Biopharma Inc., South San Francisco, CA 94080, USA. aaron.sato@lakepharma.com.
  • Hust M; Institut für Biochemie, Biotechnologie und Bioinformatik, Technische Universität Braunschweig, Braunschweig 38106, Germany. m.hust@tu-bs.de.
  • Thullier P; Unite de Biotechnologie des Anticorps, Institut de Recherche Biomedicale des Armees (IRBA-CRSSA), La Tronche 38516, France. pthullier@yahoo.com.
  • Dye JM; US Army Medical Research Institute for Infectious Disease (USAMRIID), Fort Detrick, MD 21702, USA. john.m.dye1.civ@mail.mil.
Viruses ; 10(6)2018 05 26.
Article em En | MEDLINE | ID: mdl-29861435
ABSTRACT
Sudan virus (SUDV) and Ebola viruses (EBOV) are both members of the Ebolavirus genus and have been sources of epidemics and outbreaks for several decades. We present here the generation and characterization of cross-reactive antibodies to both SUDV and EBOV, which were produced in a cell-free system and protective against SUDV in mice. A non-human primate, cynomolgus macaque, was immunized with viral-replicon particles expressing the glycoprotein of SUDV-Boniface (8A). Two separate antibody fragment phage display libraries were constructed after four immunogen injections. Both libraries were screened first against the SUDV and a second library was cross-selected against EBOV-Kikwit. Sequencing of 288 selected clones from the two distinct libraries identified 58 clones with distinct VH and VL sequences. Many of these clones were cross-reactive to EBOV and SUDV and able to neutralize SUDV. Three of these recombinant antibodies (X10B1, X10F3, and X10H2) were produced in the scFv-Fc format utilizing a cell-free production system. Mice that were challenged with SUDV-Boniface receiving 100µg of the X10B1/X10H2 scFv-Fc combination 6 and 48-h post-exposure demonstrated partial protection individually and complete protection as a combination. The data herein suggests these antibodies may be promising candidates for further therapeutic development.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Glicoproteínas de Membrana / Proteínas da Matriz Viral / Doença pelo Vírus Ebola / Ebolavirus / Profilaxia Pós-Exposição / Vacinas de Partículas Semelhantes a Vírus / Anticorpos Antivirais Tipo de estudo: Prognostic_studies Limite: Animals Idioma: En Revista: Viruses Ano de publicação: 2018 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Glicoproteínas de Membrana / Proteínas da Matriz Viral / Doença pelo Vírus Ebola / Ebolavirus / Profilaxia Pós-Exposição / Vacinas de Partículas Semelhantes a Vírus / Anticorpos Antivirais Tipo de estudo: Prognostic_studies Limite: Animals Idioma: En Revista: Viruses Ano de publicação: 2018 Tipo de documento: Article País de afiliação: Estados Unidos